Skip to main content
Premium Trial:

Request an Annual Quote

Integrated Genomics Raises Over $1M in VC Round; Plans to Develop Microbial Microarrays

NEW YORK, May 20 (GenomeWeb News) - Integrated Genomics has raised more than $1 million in a venture capital financing round, the Chicago-based company said yesterday.

 

Integrated did not disclose the exact amount of the funding or the investor. It plans to use the funds to expand its business, in particular in the area of metabolic engineering.

 

The company, which specializes in the industrial use of microorganisms, also plans to develop microarrays for quality control and process optimization for particular industries, Kathe Andrews-Cramer, Integrated's director for business development, told GenomeWeb News.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.